Products & Services
CMC Development
Peptide NCEs
Oligonucleotide NCEs
Commercial API
Commercial NCEs
Commercial Generics
Research & Specialties
Catalog Peptides
Custom Peptide Synthesis
Amino Acid Derivatives
Diagnostics
Cosmetic Peptides
Services & Capabilities
Project Management
Quality & Regulatory
Analytical capabilities
GMP Production
Research Grade Production
Supply & vertical integration
About Bachem
Company overview
Our Purpose
Our vision & strategy
Our Leadership
Our History
Our Locations
Innovation
Innovation matters
Innovation collaborations
Sustainability
People & culture
Safeguarding the environment
Acting ethically
Investors & Media
Reports & Presentations
Financial events
Media Library
Press archive
News & Events
News
Events
Careers
Contact
Select Page
Results of the capital increase
May 08, 2019
Only available in the German version.
Download
test theme builder local clear 256mb
←
Peptide Trends April 2019
Peptide Trends May 2019
→
Search for:
Innovation transforming oligonucleotide manufacturing
Bachem Earns Gold Medal Sustainability Rating from EcoVadis
Bachem Annual General Meeting 2022
Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances
A passion for shaping the future of Bachem: Interview with Diana Rinderle
Bachem’s new facilities for large-scale oligonucleotide manufacturing
Bachem achieves sales of half a billion Swiss francs
Cell-penetrating peptides: a delivery system for oligonucleotides
Bachem in Oligonucleotides: Interview with Seamus White
The thiol-maleimide reaction downside
Changes to the Bachem CEC and strengthening of the US organization
Assessing and Influencing ACE2-Mediated COVID-19 Infection
Bachem lays foundations for company’s largest production building
Bachem raises CHF 583.5 million through capital increase
Bachem launches accelerated bookbuilding for approx. 750k new shares
Extraordinary General Meeting
How are Peptides Made?
Bachem’s Commitment to Sustainability
Bachem intends a capital increase – construction of additional manufacturing site
Bachem’s liraglutide: a high-purity generic for diabetes and weight loss
